Use: Prophylaxis of DVT, which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. RECURRENT DVT AND PE RISK REDUCTION: 2.5 mg orally twice a day. Usual Adult Dose of Eliquis for Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery: ...
1.5 Reduction in the Risk of Recurrence of DVT and PE ELIQUIS is indicated to reduce the risk of recurrent DVT and PE following initial therapy. 2. Eliquis Dosage and Administration 2.1 Recommended Dose Reduction of Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillat...
Provide prophylaxis for DVT and PE in certain high-risk patients, like those undergoing knee or hip replacement surgery Reduce the risk of stroke in patients with nonvalvular atrial fibrillation If a clot forms in the veins, it can break off and lead to harmful and sometimes deadly events like...
The recommended dose of ELIQUIS is 2.5 mg taken orally twice daily after at least 6 months of treatment for DVT or PE [seeClinical Studies]. Missed Dose If a dose of ELIQUIS is not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice-d...
The recommended dose of ELIQUIS is 2.5 mg taken orally twice daily after at least 6 months of treatment for DVT or PE [seeClinical Studies]. Missed Dose If a dose of ELIQUIS is not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice-...